Published in Blood Weekly, January 1st, 2009
In addition, with ACZONE® Gel 5%, visible results may be seen in as early as two weeks, with rapid, clinically significant reduction in inflammatory lesions reported in two large, pivotal studies, 24 percent reduction at two weeks and 35 percent at four weeks. Comparatively, results...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.